pharmacovigilance

The short answer, for most organisations, is: not really. Not yet. AI is already inside pharmacovigilance and medical information workflows. Case intake tools, literature screening software, enquiry response drafting, signal detection platforms. It didn’t arrive with fanfare. It arrived quietly, embedded in systems people use every day. And in many cases, the professionals using those […]

In drug safety, the question for pharmaceutical companies isn’t whether to outsource anymore—it’s how to do it right. Pharmacovigilance outsourcing has moved well beyond simple case processing into something closer to a strategic partnership that handles everything end-to-end. Drawing on insights from industry experience, this guide covers the shift to full-service models, the compliance pitfalls […]

Pharmacovigilance tracks drug safety data to ensure medications help patients more than they hurt them. Any organization handling this work needs a solid Quality Management System to meet their regulatory obligations and actually do the job right. What a Pharmacovigilance QMS Really Is The QMS sits within your broader pharmacovigilance setup. It maps out who […]

Testing new treatments on patients with life threatening diseases requires immediate understanding of whether the treatment helps or harms. Data Safety Monitoring Boards (DSMB) provide this critical oversight. Proper auditing of these boards ensures trial integrity and patient safety. The Stakes The Challenge A DSMB requires clear rules documented in a DSMB Charter. This defines […]

In the world of Pharmacovigilance, the Drug Safety Mailbox is far more than an email address. It is the nerve center of patient safety—the first point of contact where patients, healthcare professionals, and partners report adverse events, product quality issues, and medical inquiries. Yet for many organizations, this critical mailbox has become a bottleneck. With […]

The Audit Question That No One Wants to Answer In my years conducting audits, I often paused at the Business Continuity Plan (BCP) section and asked a simple, uncomfortable question: “If the internet stops working completely for 48 hours, how will you submit your expedited safety reports to the regulatory authorities?” The answers were often […]

Antimicrobial Resistance (AMR) is often called the “silent pandemic.” It is not just a future threat; it is happening now, affecting millions of lives globally. While we often think of AMR as a clinical or public health issue, there is a powerful, underutilized weapon in our arsenal: Pharmacovigilance. Based on the latest insights, here is […]

In the world of Pharmacovigilance, we often fixate on the technical: regulatory requirements, SOPs, and data integrity. While technical expertise is non-negotiable, it is only half the battle. To truly drive improvement and ensure patient safety, an auditor must master the human element. Soft skills are not just “nice to have”; they are essential competencies […]

In the world of pharmacovigilance, few adverse events command as much respect and caution as Drug-Induced Liver Injury (DILI). It is a leading cause of acute liver failure in the Western world and remains the single most frequent safety-related reason for the withdrawal of drugs from the market. Whether you are in clinical development or […]

Aviation is a prime example of an industry where lives are at stake, and it shares striking similarities with pharmacovigilance—the science of monitoring and ensuring drug safety. Both operate in highly regulated, complex environments where human factors and automation play critical roles. Here are key lessons pharmacovigilance can learn from aviation’s extensive experience. 1. Safety […]